Alumis (ALMS) Income from Continuing Operations (2023 - 2025)
Alumis' (ALMS) quarterly Income from Continuing Operations came in at 92892000.0 in Q4 2025, down 181.75% year-on-year from 113633468.39 in Q4 2024, and up 16.13% on a QoQ basis from 110752000.0 in Q3 2025.
Alumis (ALMS) Income from Continuing Operations (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Income from Continuing Operations data on file, last reported at 92892000.0 in Q4 2025.
- On a quarterly basis, Income from Continuing Operations fell 181.75% year-over-year to 92892000.0 in Q4 2025; TTM through Dec 2025 was 250942000.0, a 8.38% decrease from a year earlier, with the FY2025 full-year figure at 243286000.0, down 4.66% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 92892000.0, up from 110752000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for ALMS reached as high as 59321000.0 in Q2 2025 and fell as low as 110752000.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 55004454.55 across 3 years, with a median of 48943000.0 in 2024.
- On a YoY basis, Income from Continuing Operations climbed as much as 204.98% in 2025 and fell as far as 181.75% in 2025.
- Year by year, Income from Continuing Operations stood at 41295000.0 in 2023, then increased by 20.16% to 32970000.0 in 2024, then sank by 181.75% to 92892000.0 in 2025.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 92892000.0 in Q4 2025, 110752000.0 in Q3 2025, and 59321000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - | -92.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -92.89 Mn |
| Sep 30, 2025 | -110.75 Mn |
| Jun 30, 2025 | 59.32 Mn |
| Mar 31, 2025 | -106.62 Mn |
| Dec 31, 2024 | -32.97 Mn |
| Sep 30, 2024 | -93.12 Mn |
| Jun 30, 2024 | -56.51 Mn |
| Mar 31, 2024 | -48.94 Mn |
| Dec 31, 2023 | -41.30 Mn |
| Sep 30, 2023 | -44.56 Mn |
| Jun 30, 2023 | -36.71 Mn |